One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy

PURPOSE: To compare the 1-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy (RF-PDT) to intravitreal ranibizumab (IVR) alone for eyes with polypoidal choroidal vasculopathy (PCV). METHODS: We reviewed the medical records from 47 consecutive patients with PCV...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sakurai, Madoka, Baba, Takayuki, Kitahashi, Masayasu, Yokouchi, Hirotaka, Kubota-Taniai, Mariko, Bikbova, Guzel, Oshitari, Toshiyuki, Yamamoto, Shuichi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2014
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913546/
https://ncbi.nlm.nih.gov/pubmed/24511222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S54578
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi